0000891293-15-000032.txt : 20150904
0000891293-15-000032.hdr.sgml : 20150904
20150904185430
ACCESSION NUMBER: 0000891293-15-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150904
FILED AS OF DATE: 20150904
DATE AS OF CHANGE: 20150904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plunkett Matthew
CENTRAL INDEX KEY: 0001557551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12465
FILM NUMBER: 151095253
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE, SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-09-04
0
0000891293
CTI BIOPHARMA CORP
ctic
0001557551
Plunkett Matthew
3101 WESTERN AVENUE, SUITE 600
SEATTLE
WA
98121
0
1
0
0
EVP, Corporate Development
Common Stock
2015-09-04
4
F
0
12526
1.52
D
659214
D
Common Stock
2015-09-04
4
S
0
5500
1.53
D
653714
D
Common Stock
2015-09-04
4
S
0
1700
1.535
D
652014
D
Common Stock
2015-09-04
4
S
0
1000
1.54
D
651014
D
common Stock
2015-09-04
4
S
0
1800
1.55
D
649214
D
Represents shares withheld by CTIC to satisfy minimum tax withholding obligations on the vesting of restricted stock.
The sale was effected pursuant to a Rule 10b5-1 trading plans.
By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett
2015-09-04